HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diana Cunha-Reis Selected Research

Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)

1/2022Opposing reduced VPAC1 and enhanced VPAC2 VIP receptors in the hippocampus of the Li2+-pilocarpine rat model of temporal lobe epilepsy.
1/2021Corrigendum: VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy.
1/2020VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy.
12/2017VPAC1 and VPAC2 receptor activation on GABA release from hippocampal nerve terminals involve several different signalling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Diana Cunha-Reis Research Topics

Disease

4Temporal Lobe Epilepsy
01/2022 - 11/2014
4Cognitive Dysfunction
01/2022 - 11/2014
2Epilepsy (Aura)
01/2022 - 12/2017
1Gliosis
01/2022
1Seizures (Absence Seizure)
01/2022
1Hippocampal Sclerosis
01/2020
1Down Syndrome (Down's Syndrome)
11/2014

Drug/Important Bio-Agent (IBA)

4Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
01/2022 - 12/2017
2LigandsIBA
01/2020 - 11/2014
1Pilocarpine (Ocusert)FDA LinkGeneric
01/2022
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2022
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
01/2022
1Type I Vasoactive Intestinal Polypeptide ReceptorsIBA
11/2014